Skip to content
10-Q/A

Quarterly Report

CORTRONIX BIOMEDICAL ADVANCEMENT TECHNOLOGIES INC.

0001524777-13-000183

← back to feed
Filed
Apr 24, 2013 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Jan 15, 2013 287M sh
Shares Diluted Q1 2013 · Nov 30, 2012 273.46M sh
Operating Cash Flow Q1 2013 · Nov 30, 2012 −$146.21K
Operating Cash Flow Q1 2013 · Nov 30, 2012 −$158.59K
Cash And Equivalents Q1 2013 · Nov 30, 2012 $49.42K
Cash And Equivalents Q1 2013 · Aug 31, 2012 $31.69K
Stockholders Equity Q1 2013 · Nov 30, 2012 −$714.86K
Stockholders Equity Q1 2013 · Aug 31, 2012 −$10.19K
Stockholders Equity Q1 2013 · Aug 2, 2012 $0
Current Liabilities Q1 2013 · Nov 30, 2012 $850.03K
Current Liabilities Q1 2013 · Aug 31, 2012 $53.77K
Current Assets Q1 2013 · Nov 30, 2012 $116.41K
Current Assets Q1 2013 · Aug 31, 2012 $33.5K
Total Assets Q1 2013 · Nov 30, 2012 $135.17K
Total Assets Q1 2013 · Aug 31, 2012 $43.58K
Sga Expense Q1 2013 · Nov 30, 2012 $31.39K
Sga Expense Q1 2013 · Nov 30, 2012 $32.71K
Net Income Q1 2013 · Nov 30, 2012 −$102.22K
Net Income Q1 2013 · Nov 30, 2012 −$113.16K
Net Income Q1 2013 · Aug 31, 2012 −$10.94K
Operating Income Q1 2013 · Nov 30, 2012 −$87.6K
Operating Income Q1 2013 · Nov 30, 2012 −$98.54K